Product Program year 2025 Source: CMS Open Payments

Estradiol

Drug Hormone Replacement

NDC 70700-145-35

Open in the dashboard

General payments

$0

0 payments

Research payments

$2,500

1 payment

Through program year 2025, $0 in general payments and $2,500 in research payments were reported against Estradiol (Hormone Replacement).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 Research $2,500 1

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

3,898,137

Prescriptions dispensed, refills included

Drug cost

$251,440,991

Paid at the pharmacy, in all

Medicare Part D drugs matched to ESTRADIOL, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Estradiol Same name 91,165 3,429,232 $184,501,746
Estring Estradiol Same name 1,603 34,179 $18,858,997
Estradiol (Twice Weekly) Estradiol Same name 7,260 167,781 $15,515,457
Yuvafem Estradiol Same name 4,312 94,098 $13,523,693
Estradiol (Once Weekly) Estradiol Same name 4,525 77,493 $5,676,140
Dotti Estradiol Same name 2,345 43,815 $4,325,142
Imvexxy Estradiol Same name 721 12,705 $4,294,787
Estradiol-Norethindrone Acetat Estradiol/Norethindrone Acet Similar name 982 16,877 $1,340,228
Climara Estradiol Same name 379 6,608 $800,097
Estradiol Valerate Similar name 270 4,783 $610,203
Vivelle-Dot Estradiol Same name 155 2,418 $553,629
Lyllana Estradiol Same name 255 4,064 $415,100
Vagifem Estradiol Same name 91 1,266 $368,795
Minivelle Estradiol Same name 51 696 $187,133
Estrace Estradiol Same name 41 511 $126,450
Divigel Estradiol Same name 40 537 $107,446
Estrogel Estradiol Same name 37 496 $101,611
Menostar Estradiol Same name 21 361 $96,342
Evamist Estradiol Same name 16 194 $33,643
Elestrin Estradiol Same name 2 23 $4,352

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 1,189 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Prema Kothandaraman Obstetrics & Gynecology CA 1,934 $147,245 None on record
My-Linh Nguyen Obstetrics & Gynecology CA 1,469 $94,663 None on record
Joann Pinkerton Obstetrics & Gynecology VA 1,354 $163,888 None on record
Carlos Fonseca Obstetrics & Gynecology PR 1,326 $111,907 None on record
James Guiler Obstetrics & Gynecology KY 1,246 $161,854 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 1,189 with Patron
1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record